110 related articles for article (PubMed ID: 20429798)
1. Association of the SLC22A1, SLC22A2, and SLC22A3 genes encoding organic cation transporters with diabetic nephropathy and hypertension.
Sallinen R; Kaunisto MA; Forsblom C; Thomas M; Fagerudd J; Pettersson-Fernholm K; Groop PH; Wessman M;
Ann Med; 2010 May; 42(4):296-304. PubMed ID: 20429798
[TBL] [Abstract][Full Text] [Related]
2. A single nucleotide polymorphism alters the sequence of SP1 binding site in the adiponectin promoter region and is associated with diabetic nephropathy among type 1 diabetic patients in the Genetics of Kidneys in Diabetes Study.
Zhang D; Ma J; Brismar K; Efendic S; Gu HF
J Diabetes Complications; 2009; 23(4):265-72. PubMed ID: 18599322
[TBL] [Abstract][Full Text] [Related]
3. Glu298Asp and NOS4ab polymorphisms in diabetic nephropathy.
Möllsten A; Wessman M; Svensson M; Forsblom C; Parkkonen M; Brismar K; Groop PH; Dahlquist G
Ann Med; 2006; 38(7):522-8. PubMed ID: 17101543
[TBL] [Abstract][Full Text] [Related]
4. Association between gene polymorphisms of SLC22A3 and methamphetamine use disorder.
Aoyama N; Takahashi N; Kitaichi K; Ishihara R; Saito S; Maeno N; Ji X; Takagi K; Sekine Y; Iyo M; Harano M; Komiyama T; Yamada M; Sora I; Ujike H; Iwata N; Inada T; Ozaki N
Alcohol Clin Exp Res; 2006 Oct; 30(10):1644-9. PubMed ID: 17010131
[TBL] [Abstract][Full Text] [Related]
5. Cloning of the mouse and human solute carrier 22a3 (Slc22a3/SLC22A3) identifies a conserved cluster of three organic cation transporters on mouse chromosome 17 and human 6q26-q27.
Verhaagh S; Schweifer N; Barlow DP; Zwart R
Genomics; 1999 Jan; 55(2):209-18. PubMed ID: 9933568
[TBL] [Abstract][Full Text] [Related]
6. Angiotensinogen gene M235T polymorphism is not associated with diabetic nephropathy. The Diabetic Nephropathy Study Group.
Schmidt S; Giessel R; Bergis KH; Strojek K; Grzeszczak W; Ganten D; Ritz E
Nephrol Dial Transplant; 1996 Sep; 11(9):1755-61. PubMed ID: 8918618
[TBL] [Abstract][Full Text] [Related]
7. Resequencing of genes for transforming growth factor beta1 (TGFB1) type 1 and 2 receptors (TGFBR1, TGFBR2), and association analysis of variants with diabetic nephropathy.
McKnight AJ; Savage DA; Patterson CC; Sadlier D; Maxwell AP
BMC Med Genet; 2007 Feb; 8():5. PubMed ID: 17319955
[TBL] [Abstract][Full Text] [Related]
8. Downregulation of organic cation transporter 1 (SLC22A1) is associated with tumor progression and reduced patient survival in human cholangiocellular carcinoma.
Lautem A; Heise M; Gräsel A; Hoppe-Lotichius M; Weiler N; Foltys D; Knapstein J; Schattenberg JM; Schad A; Zimmermann A; Otto G; Lang H; Galle PR; Schuchmann M; Zimmermann T
Int J Oncol; 2013 Apr; 42(4):1297-304. PubMed ID: 23440379
[TBL] [Abstract][Full Text] [Related]
9. CD2AP is associated with end-stage renal disease in patients with type 1 diabetes.
Hyvönen ME; Ihalmo P; Sandholm N; Stavarachi M; Forsblom C; McKnight AJ; Lajer M; Maestroni A; Lewis G; Tarnow L; Maestroni S; Zerbini G; Parving HH; Maxwell AP; Groop PH; Lehtonen S
Acta Diabetol; 2013 Dec; 50(6):887-97. PubMed ID: 23681557
[TBL] [Abstract][Full Text] [Related]
10. MTHFR C677T and A1298C gene polymorphisms and hyperhomocysteinemia as risk factors of diabetic nephropathy in type 2 diabetes patients.
Mtiraoui N; Ezzidi I; Chaieb M; Marmouche H; Aouni Z; Chaieb A; Mahjoub T; Vaxillaire M; Almawi WY
Diabetes Res Clin Pract; 2007 Jan; 75(1):99-106. PubMed ID: 16828193
[TBL] [Abstract][Full Text] [Related]
11. Variants of OCTN1-2 cation transporter genes are associated with both Crohn's disease and ulcerative colitis.
Palmieri O; Latiano A; Valvano R; D'Incà R; Vecchi M; Sturniolo GC; Saibeni S; Peyvandi F; Bossa F; Zagaria C; Andriulli A; Devoto M; Annese V
Aliment Pharmacol Ther; 2006 Feb; 23(4):497-506. PubMed ID: 16441470
[TBL] [Abstract][Full Text] [Related]
12. Differential substrate and inhibitory activities of ranitidine and famotidine toward human organic cation transporter 1 (hOCT1; SLC22A1), hOCT2 (SLC22A2), and hOCT3 (SLC22A3).
Bourdet DL; Pritchard JB; Thakker DR
J Pharmacol Exp Ther; 2005 Dec; 315(3):1288-97. PubMed ID: 16141367
[TBL] [Abstract][Full Text] [Related]
13. Possible association of SLC22A2 polymorphisms with aspirin-intolerant asthma.
Park TJ; Kim JH; Bae JS; Park BL; Cheong HS; Chun JY; Lee JS; Kim JY; Pasaje CF; Cho SH; Uh ST; Kim MK; Choi IS; Koh IS; Park CS; Shin HD
Int Arch Allergy Immunol; 2011; 155(4):395-402. PubMed ID: 21346370
[TBL] [Abstract][Full Text] [Related]
14. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin.
Yang J; Kalogerou M; Gallacher J; Sampson JR; Shen MH
Eur J Cancer; 2013 Apr; 49(6):1479-90. PubMed ID: 23228442
[TBL] [Abstract][Full Text] [Related]
15. Evidence for the association of the SLC22A4 and SLC22A5 genes with type 1 diabetes: a case control study.
Santiago JL; Martínez A; de la Calle H; Fernández-Arquero M; Figueredo MA; de la Concha EG; Urcelay E
BMC Med Genet; 2006 Jun; 7():54. PubMed ID: 16796743
[TBL] [Abstract][Full Text] [Related]
16. Parental history of hypertension and parental history of diabetes and microvascular complications in insulin-dependent diabetes mellitus: the EURODIAB IDDM Complications Study.
Roglic G; Colhoun HM; Stevens LK; Lemkes HH; Manes C; Fuller JH
Diabet Med; 1998 May; 15(5):418-26. PubMed ID: 9609365
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) in human hepatocellular carcinoma and their prognostic significance.
Heise M; Lautem A; Knapstein J; Schattenberg JM; Hoppe-Lotichius M; Foltys D; Weiler N; Zimmermann A; Schad A; Gründemann D; Otto G; Galle PR; Schuchmann M; Zimmermann T
BMC Cancer; 2012 Mar; 12():109. PubMed ID: 22439694
[TBL] [Abstract][Full Text] [Related]
18. Role of alpha-adducin DNA polymorphisms in the genetic predisposition to diabetic nephropathy.
Conway BR; Martin R; McKnight AJ; Savage DA; Brady HR; Maxwell AP
Nephrol Dial Transplant; 2004 Aug; 19(8):2019-24. PubMed ID: 15187197
[TBL] [Abstract][Full Text] [Related]
19. Heat-shock protein gene polymorphisms and the risk of nephropathy in patients with Type 2 diabetes.
Buraczynska M; Swatowski A; Buraczynska K; Dragan M; Ksiazek A
Clin Sci (Lond); 2009 Jan; 116(1):81-6. PubMed ID: 18518860
[TBL] [Abstract][Full Text] [Related]
20. Association of VEGF-1499C-->T polymorphism with diabetic nephropathy in type 1 diabetes mellitus.
McKnight AJ; Maxwell AP; Patterson CC; Brady HR; Savage DA
J Diabetes Complications; 2007; 21(4):242-5. PubMed ID: 17616354
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
